MAP2K1 and melanoma: HSP90 is a chaperone protein for several oncoproteins that contribute to melanoma cell response to inhibitors of the MAPK signaling pathway, vemurafenib (PLX; an inhibitor of BRAFV600E) and trametinib (TRA; an inhibitor of MEK1/2).